AWH Aspira Women's Health Inc. Net earnings per share growth forecast for next year

aspirawh.com (AWH) - corporate logo

The consensus earnings per share (EPS) forecast vector for Aspira Women's Health (AWH) demonstrates evolving market expectations, where 50.50 represents the current metric. Growth is supported by FDA approvals and the expansion of insurance reimbursements within the oncology diagnostics ecosystem. Aspira Women's Health (AWH) generates revenue from biomarker analysis for ovarian cancer detection, leveraging the authority of Ova1 tests and high trust within the medical community.

Aspira Women's Health, Inc. (AWH): Net earnings per share change forecast for next year from 07/04/2022 to 04/26/2025

Aspira Women's Health Inc. - analytical breakdowns and key metrics (AWH)

- share price and consensus valuation forecast:
Basic company analysis:Aspira Women's Health
Core merchandise of aspirawh.com

Investors utilize this indicator to assess business scaling rates by analyzing the expected year-over-year growth in earnings per share. This metric aggregates expert consensus forecasts, reflecting the dependence of Aspira Women's Health (AWH) revenues on the frequency of diagnostic tests and laboratory contracts, which renders the forward EPS trajectory a key signal of market expectations.

Competitor analysis for Aspira Women's Health

A (agilent.com) - Earnings growth forecast for next year|DGX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year ILMN|EXAS - Expected net earnings per share growth next year|Earnings growth forecast for next year RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Expected net earnings per share growth next year|Anbio Biotechnology - Earnings growth forecast for next year|Expected net earnings per share growth next year soterahealth.com|QDEL: Earnings growth forecast for next year|OPKO Health - Expected earnings per share trend next year|CDNA (CareDx, Inc) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year MRVI|Net earnings per share growth forecast for next year Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Expected net earnings per share growth next year|XGN - Net earnings per share growth forecast for next year|MDxHealth Inc. - Projected earnings per share increase next year|LUCD: Earnings growth forecast for next year|Prenetics Global Limited - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Insight Molecular Diagnostics, Inc.|trinitybiotech.com (TRIB) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year PRPH|Earnings growth forecast for next year Ainos Corp (AIMD)|Earnings growth forecast for next year CODX (codiagnostics.com)|Heart Test Laboratories - Net earnings per share growth forecast for next year|Biomerica Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year Cardio Diagnostics Holdings|ONCO (Onconetix Corporation) - Expected earnings per share growth for next year|Virax Biolabs Group Ltd - Expected earnings per share trend next year|Net earnings per share growth forecast for next year bluejaydx.com|AXDX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year centogene.com (CNTG)|Consensus forecast of earnings per share growth for next year Enzo Biochem|Consensus forecast of earnings per share growth for next year FRES|Net earnings per one share growth forecast for next year GTG Labs|23andMe Holding Co - Earnings growth forecast for next year|PMD - Earnings growth forecast for next year